Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review

被引:50
|
作者
Guo, Jingbo [1 ]
Shao, Jie [1 ]
Yang, Yuan [2 ]
Niu, Xiaodan [1 ]
Liao, Juan [1 ]
Zhao, Qing [1 ]
Wang, Donghui [1 ]
Li, Shuaitong [1 ]
Hu, Junping [1 ,2 ]
机构
[1] Lanzhou Univ, Sch Nursing, Lanzhou, Peoples R China
[2] Lanzhou Univ, Reprod Med Special Hosp, Key Lab Reprod Med & Embryo, Hosp 1, Lanzhou, Peoples R China
关键词
Microbiota; Polycystic ovary syndrome; Comparison; Dysbiosis; Systematic review; INSULIN-RESISTANCE; SYNDROME PCOS; WOMEN; INFLAMMATION; OBESITY; HEALTH; EXPRESSION; PARAMETERS; DYSBIOSIS; WEIGHT;
D O I
10.1007/s43032-020-00430-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary Syndrome (PCOS) is one of the most popular diseases that cause menstrual dysfunction and infertility in women. Recently, the relationships between the gastrointestinal microbiome and metabolic disorders such as obesity, type 2 diabetes and PCOS have been discovered. However, the association between the gut microbiome and PCOS symptoms has not been well established. We systematically reviewed existing studies comparing gut microbial composition in PCOS and healthy volunteers to explore evidence for this association. A systematic search was carried out in PubMed, Embase, Cochrane Library, and Web of Science from inception to May 26, 2020, for all original cross-sectional, cohort, or case-control studies comparing the fecal microbiomes of patients with PCOS with microbiomes of healthy volunteers (controls). The primary outcomes were differences in specific gut microbes between patients with PCOS and controls. The search identified 256 citations; 10 studies were included. The total population study of these articles consists of 611 participants (including PCOS group and healthy controls group). Among the included 10 studies, nine studies compared alpha-diversity, and six studies demonstrated that alpha-diversity has a significant reduction in PCOS patients. Seven of them reported that there was a significant difference of beta-diversity composition between healthy controls groups and PCOS patients. The most common bacterial alterations in PCOS patients included Bacteroidaceae, Coprococcus, Bacteroides, Prevotella, Lactobacillus, Parabacteroides, Escherichia/Shigella, and Faecalibacterium prausnitzii. No consensus has emerged from existing human studies of PCOS and gut microbiome concerning which bacterial taxa are most relevant to it. In this systematic review, we identified specific bacteria associated with microbiomes of patients with PCOS vs controls. Higher level of evidence is needed to determine whether these microbes are a product or cause of PCOS.
引用
收藏
页码:69 / 83
页数:15
相关论文
共 50 条
  • [31] Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and Mendelian randomization study
    Sun, Junwei
    Wang, Mingyu
    Kan, Zhisheng
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [32] Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome
    Zhu, Ting-Wei
    Li, Xue-Lian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2023, 50 (11) : 835 - 843
  • [33] Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population
    Mammadova, Gulnar
    Ozkul, Ceren
    Yilmaz Isikhan, Selen
    Acikgoz, Aylin
    Yildiz, Bulent O.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (04)
  • [34] Alteration in gastrointestinal health and dysbiosis of gut microbiota in women with Polycystic Ovary Syndrome
    Romualdi, D.
    De Cicco, S.
    Di Florio, C.
    Immediata, V.
    Tagliaferri, V.
    Santarsiero, C. M.
    Versace, V.
    Tropea, A.
    Lanzone, A.
    Apa, R.
    HUMAN REPRODUCTION, 2017, 32 : 473 - 473
  • [35] Gut microbiota alterations reveal potential gut–brain axis changes in polycystic ovary syndrome
    Z. Liang
    N. Di
    L. Li
    D. Yang
    Journal of Endocrinological Investigation, 2021, 44 : 1727 - 1737
  • [36] Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota
    Zhang, Mingmin
    Hu, Runan
    Huang, Yanjing
    Zhou, Fanru
    Li, Fan
    Liu, Zhuo
    Geng, Yuli
    Dong, Haoxu
    Ma, Wenwen
    Song, Kunkun
    Song, Yufan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Gut microbiota and risk of polycystic ovary syndrome: Insights from Mendelian randomization
    Li, Jing-wei
    Chen, Yu-zhi
    Zhang, Yu
    Zeng, Li-hua
    Li, Kai-wei
    Xie, Bao-zhen
    Luo, Song-ping
    Gao, Jie
    HELIYON, 2023, 9 (12)
  • [38] Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
    Sun, Yan
    Gao, Shouyang
    Ye, Cong
    Zhao, Weiliang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [39] Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report
    Liang, Yuanjiao
    Ming, Qi
    Liang, Jinlan
    Zhang, Yan
    Zhang, Hong
    Shen, Tao
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (11) : 803 - 809
  • [40] Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity
    Insenser, Maria
    Murri, Mora
    del Campo, Rosa
    Angeles Martinez-Garcia, M.
    Fernandez-Duran, Elena
    Escobar-Morreale, Hector F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07): : 2552 - 2562